Medical Countermeasures W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four CountriesGlobal Biodefense StaffMarch 19, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxGlobal Biodefense StaffMarch 12, 2025
Soligenix to Present at Chemical and Biological Defense S&T Conference Antimicrobial Resistance May 4, 2015 …
G7 Nations Call for Action on Antibiotic Resistance, Tropical Diseases Antimicrobial Resistance May 4, 2015 …
Seattle BioMed Rebrands as Center for Infectious Disease Research Medical Countermeasures April 28, 2015 …
